All work

Biotech website · Stakeholder storytelling

Skelesound

A credible biotech website that moves clinicians, investors, and research partners from complex science to conversation.

Client
Skelesound
Sector
Biotechnology · Medical devices
Delivered
2026
Visit live website
Skelesound live project homepage

The engagement

Skelesound is developing investigational vibroacoustic therapy systems. Euphemios built a polished production website that explains its precision mechanotherapy platform, distinguishes two product form factors, and gives clinicians, investors, and partners clear paths to evidence, diligence materials, and direct contact.

01

The challenge

An early-stage medical technology must make novel science understandable without overstating the evidence. Skelesound needed one professional digital platform to explain its mechanism, products, safety architecture, research direction, and commercial opportunity to three very different audiences—with investigational status and regulatory qualifications kept explicit.

02

The approach

We organized the experience around the questions each audience needs answered: what the platform is, how it works, where the evidence stands, which products are envisioned, and how to evaluate, invest, or collaborate. Scientific and product detail is paired with audience-specific briefing, evaluation, dossier, and partnership calls to action in a responsive production experience.

3priority audiences
2product form factors
16stakeholder and resource views

03

Scope of work

  • Audience journeys for clinicians, investors, and research or strategic partners
  • Platform, technology, products, evidence, safety, insights, company, and newsroom storytelling
  • Two product form factors and a software-defined therapy-program narrative
  • Audience-specific calls to action, contact routing, and regulatory disclosures
  • Responsive production experience and custom-domain launch

04

What we delivered

  • Sixteen stakeholder and resource views across the website
  • Platform, product, evidence, safety, and company narratives
  • Audience-specific evaluation, diligence, technical, and partnership calls to action
  • Investigational and regulatory qualifications integrated throughout
  • Responsive production deployment on the public domain

05

The result

  1. 01

    Skelesound now has one professional production home for its scientific, product, and company narrative.

  2. 02

    Three priority audiences can reach evidence, opportunity, or collaboration material without navigating one generic pitch.

  3. 03

    High-intent actions support clinical evaluation, investor diligence, technical review, and partnership conversations.

  4. 04

    Investigational status, provisional specifications, and safety qualifications accompany the product story, strengthening credibility without implying regulatory approval.

Built with